Markus Renschler is the founder of Cyteir Therapeutics. Cyteir Therapeutics has raised $140M in total funding. Latest round: Series C.
Markus Renschler, MD, is the CEO of Cyteir Therapeutics, a biotechnology company focused on synthetic lethal therapies for cancer. He is a former Celgene executive who led Cyteir through an $80 million Series C financing round. He also serves as CEO of Light Horse Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library